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Abstract
Background: Due to low vaccine coverage, Japan has not only experienced outbreaks of measles
but has also been exporting it overseas. This study aims to survey measles vaccine coverage and
the factors uncompleted vaccination among community-living children.
Methods: Subjects were the parents whose children had undergone either an 18-month or a 36-
month checkup publicly provided by Kyoto City during November 2001 to January 2002. An
anonymous self-administered questionnaire survey was conducted.
Results: The coverage was 73.2% among the 18-month-old children (n = 2707) and 88.9% among
the 36-month-old children (n = 2340), respectively. The following characteristics of mothers were
related to uncompleted measles vaccination: aged below 30, working, concerned about the adverse
events of the vaccine, and had insufficient knowledge. Similarly, the following characteristics among
children were related to uncompleted measles vaccination: not the first-born child, interacting with
other children in group settings. The coverage was the lowest among the children whose mothers
were concerned about the adverse events of the vaccine without proper knowledge of measles and
its vaccination.
Conclusion: To increase vaccine coverage among children, parents' awareness about measles and
vaccination against it should be promoted, especially for working mothers. Efforts to enhance
access to vaccination services and to communicate with parents about changing vaccination
schedules are necessary.
Background
Despite the existence of a safe, effective, and inexpensive
vaccine, measles is still not being controlled in many parts
of the world. The use of measles vaccine over the last 30
years has reduced global measles morbidity and mortality
by 74 and 85%, respectively, compared with the prevac-
cine era. Regional elimination goals have been established
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in the Americas (by 2000), Europe (by 2007) and the East-
ern Mediterranean (by 2010) [1].
Vaccine coverage in excess of 95% interrupts endemic
transmission of measles in many countries, but achieve-
ment of such coverage almost always requires great collab-
orative efforts. [2] The global strategy began in the 1990s
and many countries implemented immunization and
enhanced measles surveillance policies related to this dur-
ing the late 1990's. Some (e.g. the Americas) achieved
measles elimination quite early [2,3]. Since 2000, the
WHO and UNICEF have recommended that, in addition
to achieving high coverage with the first dose of measles
vaccine, all children should be offered a second opportu-
nity for measles vaccination to increase the total number
of people who are immune [4].
In the United States, measles was targeted for elimination,
and persisted at low incidence until 1989, when an epi-
demic swept the country. To prevent spread among
school-age populations, a second dose of MMR vaccine is
recommended. To increase immunization coverage
among inner-city preschool populations, a number of
activities have been undertaken to improve the immuni-
zation delivery system[5,6]. Today, measles has been
eliminated in the United States [7].
During 1997 and 2001, a total of 156 (82%) of 191 coun-
tries provided a second opportunity to receive a vaccina-
tion through supplementary immunization activities or
through routine health services. Japan remains as one of
the remaining 35 countries that do not give a second
opportunity for measles vaccination [4]. Of the 26
imported measles cases detected in the US in 2000, the
largest number of these cases was from Japan (seven
cases). In 2000, Japan is reported to be the principal
exporting country of measles to the US [7].
The Immunization Law in Japan has been providing chil-
dren with measles vaccination since 1978. Since Measles-
mumps-rubella (MMR) vaccine was introduced into
Japan in 1989, a number of cases of post-vaccination
aseptic meningitis have been reported and these have
been attributed to the use of Urabe Am9 mumps vaccine
[8]. In 1993, the Ministry of Health and Welfare (MHW)
withdrew the domestically produced MMR vaccine [9]. As
of 1994, an amendment to the Immunization Law made
vaccination voluntary and not mandatory. According to
the present law, a single dose of measles vaccine is recom-
mended for children over one year of age. Children are eli-
gible to receive measles vaccination after 12 months
following birth but not beyond 90 months. Until January
2004, adminisiration of measles vaccine was recom-
mended between 12 and 24 months of age, instead of
between 12 and 15 months when children have the great-
est risk of contracting measles [10]. In Japan, measles vac-
cine coverage has remained low, and either small or
moderate outbreaks have occurred repeatedly in commu-
nities. According to an infectious disease surveillance
(2000), total measles cases were estimated to be from
180,000 to 210,000, and total deaths were estimated to be
88 [11,12]. Measles cases are most frequently observed
among non-immunized children, particularly between 12
to 24 months. However, a nation-wide survey conducted
in 2000 showed that measles vaccine coverage in Japan
was 81.4%, which is not enough to prevent outbreaks
[13]. In this context, the Japan Pediatric Association, the
Japan Child Health Association, and the Japanese Associ-
ation of Pediatrics jointly appealed to the Ministry of
Health, Labor and Welfare to promote vaccination against
measles in July 2001 [14]. Although secondary vaccine
failure (SVF) has increased in Japan and discussion on two
dose measles immunization has begun [15,16], actual
increase in vaccine coverage among children between 12
to 24 months-old become a priority in the present setting.
The level of vaccine coverage within a community is nec-
essary to develop appropriate measures. Still, no public
system in Japan is capable of providing such information
on a regular basis.
The purpose of the present study is to examine the follow-
ing: measles vaccine coverage among 18-month-old and
36-month-old children; parents' knowledge of and per-
ceptions about measles and its vaccination; and factors
related to uncompleted measles vaccination in Japanese
local communities.
Methods
The present survey was conducted in Kyoto City, an area
that covers 610 km2 and is situated in the middle of the
Kinki district of Japan and has a population of 1.47 mil-
lion as of October 2001. The number of one-year-olds and
three-year-olds in Kyoto City are approximately 12,000
respectively. The survey covers a period of three months
extending from November 2001 to January 2002. Subjects
were parents of children who had received either an 18-
month or a 36-month checkup at either one of the 11
health centers or the three substations in Kyoto City. In
Japan, parents are encouraged to have their children
receive 18-month and 36-month checkups at public
health centers. The present survey was conducted in coop-
eration with the Kami-gyo Public Health Center located in
Kyoto City. An anonymous self-administered question-
naire was sent out to each subject, enclosed with a pre-
consultation form, which is usually posted to the parents
prior to the health checkup. Questionnaire, which sub-
jects completed at home, were collected on the day of the
checkup. The questionnaire included items on relevant
attributes of parents (e.g. gender, age, job status); relevant
attributes of children (e.g. birth order, whether or not theyBMC Public Health 2005, 5:59 http://www.biomedcentral.com/1471-2458/5/59
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interacted with other children in group settings (e.g.
attending nursery schools), and presence/absence of
allergy); the child's vaccination history; whether or not
the child had contracted measles in the past; reasons for
not receiving measles vaccination (if the relevant child
had not been vaccinated against measles); knowledge
regarding measles and its vaccination, and sources of
information regarding measles vaccination.
Questionnaire items regarding knowledge of measles and
its vaccination were developed based on a survey con-
ducted in 1991, which investigated parents' awareness of
the plausible grave consequences of contracting measles
and the importance of measles vaccination [17].
This study's outcome measure is defined as measles vac-
cine coverage among 18 – and 36-month-old children. A
logistic regression analysis was carried out to assess the
factors related to uncompleted measles vaccination. To
investigate how different levels of knowledge regarding
measles and its vaccination, and varying degrees of con-
cern for possible adverse events could influence uncom-
pleted measles vaccination, the respondents were
categorized into four groups according to their levels of
knowledge and degree of concern. Respondents were also
divided into a "low knowledge" group and a "high knowl-
edge" group based on the median split of their total scores
on a set of questions regarding knowledge of measles and
its vaccination. A score of 0–6 points among the 18-
month-old group and a score of 0–5 points among the 36-
month-old group was deemed as indicative of "low
knowledge", while a score of 7–12 points among the 18-
month-old group and a score of 6–12 points among the
36-month-old group was deemed as indicative of "high
knowledge." Results of the logistic regression analysis car-
ried out using three dummy variables, namely X1, X2 and
X3, are shown in Table 1.
Statistical software (JMP4J, SAS institute) was used to
carry out the analysis. For the validation study, the sub-
ject's answer to the question regarding the child's vaccina-
tion history was checked against the child's Personal
Health Record Book (this control was conducted only for
a certain number of subjects).
Results
The number of children who received a health checkup 
and the response rate
During the survey period, 90.6% of 18-month-old chil-
dren (3072 out of 3391) and 85.7% of 36-month-old
children (2836 out of 3308) in the city received a health
checkup. The response rate was 88.1% (2707 respondents
out of 3072 patients who received a health checkup) and
82.5% (2340 respondents out of 2836 patients who
received a health checkup). Because the majority of par-
ents who responded to the questionnaire were mothers
(98.1% of respondents among the 18-month-old group
and 99.8% of respondents among the 36-month-old
group), the analysis was conducted under the assumption
that all respondents were mothers.
Measles vaccine coverage and incidence of measles
Measles vaccine coverage was calculated by dividing
number of respondents whose children had been vacci-
nated against measles by total number of respondents.
Coverage was 73.2% among the 18-month-old group and
88.9% among the 36-month-old group. In both groups,
there were 44 children with a history of measles. The
cumulative incidence of measles was calculated as 1.6%
for the 18-month-old group and 1.9% for the 36-month-
old group. In both groups, measles incidence was signifi-
cantly higher among children who interacted with other
children in group settings compared to children who did
not. (18-month-old group: 3.3% (95%CI: 2.1–5.1) vs.
1.2% (95%CI: 0.8–1.7), 36-month-old group: 2.9%
(95%CI: 2.0–4.3) vs. 1.3% (95%CI: 0.8–2.0))
To test validity, we compared responses about their chil-
dren's history of measles vaccination from all respondents
whose children received a health checkup at Kami-gyo
Public Health Center during this survey period with the
data registered in their children's Personal Health Record
Books. Results showed that 98.2% of respondents (108
out of 110 respondents) in the 18-month-old group and
Table 1: Characteristics of group 1~4
knowledge concern dummy variable Number
18-month group 36-month group
Group 1 high Low 690 748
Group 2 low Low X1 1145 813
Group 3 high high X2 367 379
Group 4 low high X3 418 306BMC Public Health 2005, 5:59 http://www.biomedcentral.com/1471-2458/5/59
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98.3% of respondents (117 out of 119 respondents) in
the 36-month-old group provided valid answers regarding
their children's history of measles vaccination.
The reasons for not receiving measles vaccine
Respondents whose children had not been vaccinated
against measles (698 18-month-old children and 211 36-
month-old children) were asked about the reasons for not
having their child be vaccinated. (Table 2) In both groups,
the majority of respondents replied that either they had
not received vaccination but were planning to in the near
future or that they had wanted to receive vaccination but
had missed the opportunity to do so. The percentage of
respondents who indicated concern about adverse events
from a vaccination was 2.9% among the 18-month-old
group and 9.5% among the 36-month-old group, with the
percentage being slightly higher for the latter group.
Knowledge about measles
The percentage of respondents who were aware that all
children should be vaccinated against measles once they
have reached the age of one was 78.7% among the 18-
month-old group and 71.7% among the 36-month-old
group. While approximately half of respondents were
aware that measles is a highly contagious disease with
symptoms of fever and rashes, only about 30% were
aware that there have been cases of death from measles in
Japan or that measles-infected children can suffer from
Table 2: Reasons for not receiving measles vaccination (multiple answers)
18-month-old group 36-month-old group
Number of non-vaccinated children n = 698 n = 211
%%
has not yet received measles vaccination but is going to receive it in the near future 76.2 46.9
had a cold at the time of vaccination 32.5 24.2
had to receive other vaccinations first 23.5 11.4
wanted to receive measles vaccination but missed the chance to receive it 22.2 34.1
wasn't aware of/forgot about the vaccination schedule 6.9 9.5
was sick at the time of vaccination 4.9 1.9
has already been infected with measles 4.9 11.8
was concerned about adverse events of measles vaccination 2.9 9.5
naturally acquired immunity seems more effective than artificially acquired immunity 2.4 4.7
vaccination is no longer mandatory 2.4 6.6
vaccination does not seem to be sufficiently effective 0.7 1.4
Others 5.4 3.3
Table 3: Knowledge about measles among the mothers of children eligible for 18-month or 36-month checkup
Percentage of respondents answering "yes"
18-month group 36-month group
Participants n = 2707 n = 2340
All children should be vaccinated against measles once they have reached the age of one 78.7 71.7
Measles is accompanied by high fever 74.1 76.2
Measles is accompanied by rashes 72.6 73.7
Measles is highly contagious 66.4 67.9
Most people can be immunized against measles through vaccination 50.4 51.0
The best way to prevent measles is through vaccination 45.1 45.7
Severe cases of measles are more likely to occur in younger children 41.6 34.4
There are some reported cases of death from measles in Japan 40.7 37.6
Measles can cause encephalitis 37.6 38.4
Some measles-infected children may suffer from the sequelae of measles 30.7 30.7
Measles can cause pneumonia 26.0 24.0
Measles is accompanied by severe coughing 10.0 8.8BMC Public Health 2005, 5:59 http://www.biomedcentral.com/1471-2458/5/59
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the sequelae of measles. (Table 3) There were a total of 12
questions regarding knowledge of measles, with one point
assigned to each question. The median of the total score
for the 12 questions were 6 points in the 18-month-old
group and 5 points in the 36-month-old group.
Predictors of uncompleted measles vaccination
A logistic regression analysis was conducted considering
the following variables: mother's age (< 30 years), mother
working, not first born child, interaction with other chil-
dren in group settings, presence of allergies in child,
mother having concern about the adverse events of mea-
sles vaccination, "low knowledge" about measles. (Table
Table 4: Factors related to uncompleted measles vaccination (univariate analysis)
variable Prevalence (%) Odds Ratio (95% CI) P value
18-month group Mother's age (< 30 years) 36.7 1.11 (0.93, 1.32) 0.26
Mother working 25.1 1.66 (1.37, 2.01) <0.0001
Not first born child 45.5 1.93 (1.62, 2.30) <0.0001
Interaction with other children 21.2 1.76 (1.44, 2.15) <0.0001
Presence of allergy 17.8 0.90 (0.71, 1.13) 0.37
Concern about adverse events 30.0 1.30 (1.07, 1.56) 0.007
Low knowledge 60.7 2.09 (1.73, 2.53) <0.0001
36-month group Mother's age (< 30 years) 22.5 1.32 (0.95, 1.81) 0.09
Mother working 33.3 2.60 (1.95, 3.49) <0.0001
Not first born child 46.5 2.04 (1.53, 2.74) <0.0001
Interaction with other children 38.3 2.64 (1.98, 3.54) <0.0001
Presence of allergy 27.9 1.31 (0.96,1.76) 0.09
Concern about adverse events 30.5 1.52 (1.12, 2.05) 0.01
Low knowledge 51.1 1.91 (1.43,2.58) <0.0001
CI: Confidence Intervals
Table 5: Factors related to uncompleted measles vaccination (multivariate analysis)
18 month group 36 month group
Variable Odds Ratio (95% CI) P value Odds Ratio (95% CI) P value
Mother's age (< 30 
years)
1.29 (1.06, 1.59) 0.01 1.67 (1.15, 2.40) 0.007
Mother working 1.38 (1.00, 1.89) 0.05 1.75 (1.16, 2.66) 0.008
Not first born 
child
2.24 (1.84, 2.73) <0.0001 2.38 (1.71, 3.34) <0.0001
Interaction with 
other children
1.57 (1.13, 2.18) 0.008 1.90 (1.24, 2.89) 0.003
Presence of allergy 0.84 (0.66, 1.07) 0.17 1.23 (0.88, 1.71) 0.22
High knowledge, 
low concern 
(Group 1)
1.00 1.00
Low knowledge, 
low concern 
(Group 2)
2.14 (1.67, 2.75) <0.0001 2.08 (1.38, 3.19) 0.001
High knowledge, 
high concern 
(Group 3)
1.36 (0.97, 1.90) 0.07 1.69 (1.01, 2.79) 0.04
Low knowledge, 
high concern 
(Group 4)
3.67 (2.74, 4.93) <0.0001 3.69 (2.30, 5.94) <0.0001
CI: Confidence IntervalsBMC Public Health 2005, 5:59 http://www.biomedcentral.com/1471-2458/5/59
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4) Respondents were divided into a "low knowledge"
group and a "high knowledge" group based on the
median split of their scores on a set of questionnaire items
related to the knowledge of measles and its vaccination.
Among the variables related to mothers' characteristics,
working and concern about adverse events of measles vac-
cination, and "low knowledge" of measles were signifi-
cantly associated with uncompleted measles vaccination.
Among variables related to child's characteristics, not first
born child and interaction with other children were signif-
icantly associated with uncompleted measles vaccination.
To investigate how different levels of knowledge regarding
measles and its vaccination and varying degrees of
concern about possible adverse events could influence
uncompleted vaccination, respondents were categorized
into four groups according to their levels of knowledge
(cutoff points = the median values) and degree of concern.
This logistic regression analysis was carried out using three
dummy variables, namely, X1, X2 and X3. (Table 1)
Results showed that the odds ratio of uncompleted mea-
sles vaccination was highest for Group 4 (i.e. "low knowl-
edge" and high concern about adverse events), followed
by Group 2 ("low knowledge" and low concern about
adverse events), Group 3 ("high knowledge" and high
concern about adverse effects), and Group 1 ("high
knowledge" and low concern about adverse events).
(Table 5) Among the 18-month-old group, measles vac-
cine coverage was 73.2%, the odds ratio may be inflated
as an approximate value of the risk ratio.
Discussion
Since 1978, measles vaccination has become part of rou-
tine vaccination schedules in Japan. Following the
amendment to the Immunization Law in 1994, vaccina-
tion has become voluntary. According to this law, a single
dose measles vaccine schedule is recommended for chil-
dren over one year of age. Children are eligible to receive
measles vaccination after 12 months following birth but
not exceeding 90 months. In January 2004, a recommen-
dation was issued that children should be vaccinated
between 12 and 15 months of age, not between 12 and 24
months as it was previously. This change was proposed as
a measure to prevent increased incidence of measles
among non-vaccinated one-year-old children. Optional
vaccination is available for individuals who are now older
than the conventional age of vaccination. Due to low vac-
cine coverage, small or moderate outbreaks of measles are
quite common in Japan. Although most infections occur
in non-vaccinated young children around the age of one-
year-old, cases of adult measles has also been on the rise
[18-20]. Approximately 60% of reported measles cases in
Japan involve people under the age of five years without a
history of vaccination, and an increase in vaccination cov-
erage at age one may be decreasing by approximately half,
the total number of all measles patients [21].
To increase vaccine coverage against measles, an accurate
estimate of the current rate of vaccine coverage is required.
Presently, the coverage rate is calculated by dividing total
number of persons vaccinated per year by total number of
children between the ages of 12 and 24 months [11]. This
formula does not accurately represent the actual number
of children who have or have not been vaccinated against
measles. In Japan, local governments are responsible for
vaccination in their respective populations. Vaccination
policy thus differs across different cities, towns and vil-
lages (namely, individual or mass vaccination, provided
with or without charge, and vaccination age ranging from
12 to 18 months). Approximately 90% of local govern-
ments in Japan, including Kyoto City, provide vaccination
to children who are older than one-year on an individual
basis without charge [13]. According to the nation-wide
survey conducted in 2000 (total number of persons vacci-
nated against measles per year over total number of per-
sons who were going to receive vaccination per year),
measles vaccine coverage in Japan is 81.4%, surpassing
80% for the first time since the survey initially began [13].
This survey's methodology, however, is problematic. The
definition of denominator (total number of persons who
were going to receive vaccination per year) differs across
individual local governments. To obtain vaccine coverage
is important for each local government.
Kyoto City experienced moderate-scale measles outbreaks
in 1984, followed by smaller outbreaks in 1987, 1992 and
1997 at five-year intervals. The number of reported cases
of measles at one point in 2001 was 205, with no reported
cases of further spread. A further report identified that
44.4% of all measles cases occur in children ages two or
below [22].
In the present survey, measles vaccine coverage, which
was calculated by simply dividing the number of respond-
ents whose children had been vaccinated by total number
of respondents, was 73.2% among the 18-month-old
group and 88.9% among the 36-month-old group. The
percentage of children in Kyoto City that actually received
health checkup was 90.6% among 18-month-olds and
85.7% among 36-month-olds. Because it can be assumed
that vaccine coverage rate may be lower among children
who do not receive health checkups, actual coverage rate
may also be lower than that indicated in the present study.
Several previous surveys in Japan report vaccine coverage
among 18-month children to be around 70% and that
among 36-month children to be around 90% [23-25].
These findings are consistent with the present study. Sev-
eral studies have also reported that factors related to aBMC Public Health 2005, 5:59 http://www.biomedcentral.com/1471-2458/5/59
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child-bearing environment, such as young motherhood,
mother working, not being the first-born child, and
attending nursery school, may contribute to low vaccine
coverage [23-25]. Our findings agree. The present study
also confirmed that factors such as concern about adverse
events and low levels of knowledge were significantly
associated with uncompleted measles vaccination. We
checked for colinearity in the multivariate regression
model. The correlation coefficients except among
"mother working" and "interaction with other children"
was 0.01–0.29. Although the correlation coefficients
among "mother working" and "interaction with other
children" was high (0.75 in 18-month group and 0.66 in
36-month group), these are different matters and we are
interested in both of them. We put both of them into the
final model, and got the result that we can interpret.
Lieu textitet al. examined the MMR vaccination history
among 15-month-old children from affluent families and
the factors that may delay vaccination. These factors were:
having a large number of children, not having a regular
doctor, not knowing when the shot was due, and not wor-
rying about the risk of shots [26]. The present study
showed that measles vaccine coverage was lowest among
the group of children whose mothers were concerned
about the adverse events of the vaccine without proper
knowledge of measles and its vaccination (the coverage:
was 18-month-old group: 61.9%, 36-month-old group:
85.0%). Even among mothers who indicated their con-
cern about adverse events, the odds ratio of uncompleted
measles vaccination was higher in those who had insuffi-
cient knowledge regarding measles and its vaccination.
These results suggest that the level of knowledge is more
highly correlated with immunization status than the level
of concern about adverse events; this highlights the
importance of promoting awareness among parents
regarding measles vaccination. Effort is needed to
improve benefit and risk communication [27]. Most
important to vaccination is a balanced approach to the
potential risks of natural infection, vaccine benefits, and
adverse reactions to the vaccine. Given the potential risk
of natural measles infection and the vaccine's efficiency
and safety, the benefits are obvious [21].
As part of a campaign to raise awareness of measles vacci-
nation in Japan among parents whose children are about
to be enrolled in nursery schools, kindergartens and ele-
mentary schools, the Japanese Medical Association and
the Japanese Association of Pediatrics have jointly
launched a Vaccination Week for Children in March,
2004. During this Vaccination Week, consultation regard-
ing measles vaccination was available to parents, and vac-
cination was carried out both on Saturday and Sunday.
Conclusion
In order to promote measles vaccination, further consid-
eration should be given to the following measures: to pro-
mote awareness about measles, the benefits of measles
vaccine, and the possibility of adverse events from vacci-
nation among parents, especially among those who are
aged below 30 or those who have two or more children;
to establish a system to enhance access to vaccination
services by, for example, providing vaccination services at
nights and on weekends, and; to encourage and support
nursery school staff in promoting vaccination as well as in
collecting vaccination history data about the children.
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